BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7499858)

  • 1. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase.
    Mĕlková Z; Esteban M
    J Immunol; 1995 Dec; 155(12):5711-8. PubMed ID: 7499858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites.
    Karupiah G; Harris N
    J Exp Med; 1995 Jun; 181(6):2171-9. PubMed ID: 7539042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes.
    Drillien R; Spehner D; Bohbot A; Hanau D
    Virology; 2000 Mar; 268(2):471-81. PubMed ID: 10704355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus.
    Lee SB; Esteban M
    Virology; 1993 Apr; 193(2):1037-41. PubMed ID: 8096351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line.
    Mĕlková Z; Esteban M
    Virology; 1994 Feb; 198(2):731-5. PubMed ID: 8291253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL; Moss B
    Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors.
    De Silva FS; Moss B
    Virol J; 2005 Mar; 2():23. PubMed ID: 15784143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
    Ramsey-Ewing A; Moss B
    Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation.
    Granja AG; Sabina P; Salas ML; Fresno M; Revilla Y
    J Virol; 2006 Nov; 80(21):10487-96. PubMed ID: 17041221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.
    Yu JS; Tsai HC; Wu CC; Weng LP; Li HP; Chung PJ; Chang YS
    Oncogene; 2002 Nov; 21(52):8047-61. PubMed ID: 12439755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vaccinia virus replication by adenosine in BSC-40 cells: involvement of A(2) receptor-mediated PKA activation.
    Leão-Ferreira LR; Paes-De-Carvalho R; De Mello FG; Moussatché N
    Arch Virol; 2002 Jul; 147(7):1407-23. PubMed ID: 12111415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).
    Esteban M; Patiño C
    J Interferon Cytokine Res; 2000 Oct; 20(10):867-77. PubMed ID: 11054274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM; Chen B; Fodor I
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antiviral effect of nitric oxide: inhibition of reovirus replication.
    Pertile TL; Karaca K; Sharma JM; Walser MM
    Avian Dis; 1996; 40(2):342-8. PubMed ID: 8790884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin differentially inhibits picornavirus, herpesvirus and poxvirus replication in a human carcinoma cell line.
    Nørskov-Lauritsen N; Ebbesen P
    In Vivo; 1993; 7(6A):481-5. PubMed ID: 7514894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.
    Rolph MS; Cowden WB; Medveczky CJ; Ramshaw IA
    J Virol; 1996 Nov; 70(11):7678-85. PubMed ID: 8892888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2000 May; 271(2):353-7. PubMed ID: 10799301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of polyadenylated nontranslated small RNA sequences (POLADS) during superinfection correlates with the inhibition of viral and cellular protein synthesis.
    Bablanian R; Scribani S; Esteban M
    Cell Mol Biol Res; 1993; 39(3):243-55. PubMed ID: 7507390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.
    Rolph MS; Ramshaw IA; Rockett KA; Ruby J; Cowden WB
    Virology; 1996 Mar; 217(2):470-7. PubMed ID: 8610438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.